Loading company
Bionano Genomics, Inc.
BNGO · Nasdaq · ·
$1.72+1.8%Sep 29 close
- 1M
- +47.0%
- 6M
- +52.2%
- 1Y
- +0.6%
- 5Y
- -99.9%
BNGO · Nasdaq · ·
$1.72+1.8%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $8.2M | $6.7M | +21.36% |
| Profit | -$7.4M | -$6.9M | -8.25% |
| Profit per share | -$0.64 | -$1.99 | +67.84% |
| Free Cash Flow | -$20.3M | -$11M | -84.76% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Bionano Genomics, Inc. has no earnings call transcript available.
Releases land after the close or before the open, so the move is the session that follows.
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Bionano Genomics, Inc.’s Item 2.02 8-K filed August 10, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.